Magnetic stimulation to relieve low back pain and preserve muscle in people with end-stage kidney disease
The Effect of Magnetic Stimulation on Low Back Pain Relief and Muscle Mass Maintenance in Patients With End-Stage Renal Disease (ESRD)
This test uses magnetic stimulation to try to reduce low back pain and help maintain muscle mass in adults on frequent dialysis for end-stage renal disease.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 18 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Bundang CHA Hospital Academic / other |
| Locations | 1 site (Seongnam-si, Gyeonggi-do) |
| Trial ID | NCT06982573 on ClinicalTrials.gov |
What this trial studies
This interventional trial applies targeted magnetic stimulation to patients with end-stage renal disease who report moderate to severe low back pain and are on dialysis more than three times a week. Pain intensity and muscle mass will be measured before and after a course of magnetic stimulation to see if symptoms improve and muscle is preserved. Eligible participants must be adults (≥19 years), cognitively able to report pain (MMSE ≥23), and have a baseline pain score of 4 or higher on the visual analogue scale. Patients with pain from trauma, severe psychiatric or neurological illness, or unstable cardiovascular conditions are excluded.
Who should consider this trial
Good fit: Adults aged 19 or older with end-stage renal disease on dialysis more than three times per week who have a VAS low back pain score of 4 or higher and intact cognition capable of giving informed consent.
Not a fit: Patients whose pain is due to recent trauma, who have severe neurological or psychiatric disorders, unstable cardiovascular disease, or significant cognitive impairment are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, this approach could reduce chronic low back pain and help preserve muscle mass in dialysis patients, improving comfort and physical function.
How similar studies have performed: Related magnetic stimulation and neuromodulation studies have shown mixed but promising results for chronic low back pain and muscle activation in other populations, though evidence specifically in dialysis patients is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 19 years or older 2. Patients diagnosed with end-stage renal failure and receiving dialysis treatment more than three times a week 3. Back pain intensity of 4 points or higher on the visual analogue scale (VAS) 4. Those with cognitive function that can clearly indicate NRS with a score of 23 points or higher, the criterion for determining cognitive impairment on the Mini Mental State Examination (MMSE) \[14\] 5. Those who voluntarily decided to participate in this clinical trial after receiving a detailed explanation and fully understanding it and gave written consent to comply with the precautions Exclusion Criteria: 1. If the pain is due to trauma 2. If it is difficult to participate in the study due to serious mental illness (e.g. schizophrenia, bipolar disorder, etc.) or psychological instability. 3. Patients with severe neurological illness (e.g. stroke, severe dementia, etc.). 4. Those with poor general condition due to unstable cardiovascular, digestive, respiratory, or endocrine systems, or severe internal medical illness such as systemic infection 5. Patients participating in other therapeutic clinical trials or those who have participated in other therapeutic clinical trials within the past 30 days (observational studies are not relevant) 6. If there are contraindications to magnetic stimulation * Patients with implanted medical devices (e.g. pacemakers) * Metal objects are inserted into the skull * A wound on the skin at the attachment site * History of epilepsy * Cervical pain or musculoskeletal disease * Pregnant and lactating women
Where this trial is running
Seongnam-si, Gyeonggi-do
- CHA Bundang Medical Center, CHA University — Seongnam-si, Gyeonggi-do, South Korea (Recruiting)
Study contacts
- Principal investigator: Kim Minyoung, M.D., Ph.D — Bundang CHA Hospital
- Study coordinator: Chung Eun Hye, M.S
- Email: a230419@chamc.co.kr
- Phone: +821032657071
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.